BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 11477358)

  • 1. Ligand density determines the efficiency of negative selection in the thymus.
    Römermann D; Heath WR; Allison J; Bayer B; Sorge Y; Miller JF; Hoffmann MW
    Transplantation; 2001 Jul; 72(2):305-11. PubMed ID: 11477358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive selection of thymocytes expressing the same TCR by different MHC ligands results in the production of functionally distinct thymocytes distinguished by differential expression of the heat stable antigen.
    Teh HS; Motyka B; Teh SJ
    J Immunol; 1998 Jan; 160(2):718-27. PubMed ID: 9551907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice.
    Zhou T; Bluethmann H; Eldridge J; Brockhaus M; Berry K; Mountz JD
    J Immunol; 1991 Jul; 147(2):466-74. PubMed ID: 1830064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Threshold tolerance in H-2Kb-specific TCR transgenic mice expressing mutant H-2Kb: conversion of helper-independent to helper-dependent CTL.
    Auphan N; Jézo-Brémond A; Schönrich G; Hämmerling G; Arnold B; Malissen B; Schmitt-Verhulst AM
    Int Immunol; 1992 Dec; 4(12):1419-28. PubMed ID: 1286065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene.
    Strasser A; Harris AW; von Boehmer H; Cory S
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1376-80. PubMed ID: 8108419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
    Schneider MK; Grönvik KO
    Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities.
    Bogen B; Gleditsch L; Weiss S; Dembic Z
    Eur J Immunol; 1992 Mar; 22(3):703-9. PubMed ID: 1547816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of mature T cell populations in the thymus: CD4 or CD8 down-regulation occurs at different stages of thymocyte differentiation.
    Marodon G; Rocha B
    Eur J Immunol; 1994 Jan; 24(1):196-204. PubMed ID: 7912676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The T cell receptor repertoire of CD4-8+ thymocytes is altered by overexpression of the BCL-2 protooncogene in the thymus.
    Tao W; Teh SJ; Melhado I; Jirik F; Korsmeyer SJ; Teh HS
    J Exp Med; 1994 Jan; 179(1):145-53. PubMed ID: 8270861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of phenotypically distinct NK1.1+ T cells upon antigen expression in the thymus or in the liver.
    Legendre V; Boyer C; Guerder S; Arnold B; Hämmerling G; Schmitt-Verhulst AM
    Eur J Immunol; 1999 Jul; 29(7):2330-43. PubMed ID: 10427996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection.
    Wang CR; Hashimoto K; Kubo S; Yokochi T; Kubo M; Suzuki M; Suzuki K; Tada T; Nakayama T
    J Exp Med; 1995 Mar; 181(3):927-41. PubMed ID: 7532685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD45 enhances positive selection and is expressed at a high level in large, cycling, positively selected CD4+CD8+ thymocytes.
    Ong CJ; Dutz JP; Chui D; Teh HS; Marth JD
    Immunology; 1997 May; 91(1):95-103. PubMed ID: 9203971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct requirements of positive and negative selection for selecting cell type and CD8 interaction.
    Schönrich G; Strauss G; Müller KP; Dustin L; Loh DY; Auphan N; Schmitt-Verhulst AM; Arnold B; Hämmerling GJ
    J Immunol; 1993 Oct; 151(8):4098-105. PubMed ID: 8104994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered thymocyte development resulting from expressing a deleting ligand on selecting thymic epithelium.
    Carlow DA; Teh SJ; Teh HS
    J Immunol; 1992 May; 148(10):2988-95. PubMed ID: 1578126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 expression up to the double-positive CD3(low/intermediate) stage of thymic differentiation is sufficient for development of peripheral functional cytotoxic T lymphocytes.
    Zhang XL; Zhao S; Borenstein SH; Liu Y; Jayabalasingham B; Chamberlain JW
    J Exp Med; 2001 Sep; 194(5):685-93. PubMed ID: 11535636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4-CD8- thymocytes that express the T cell receptor may have previously expressed CD8.
    Wu L; Pearse M; Egerton M; Petrie H; Scollay R
    Int Immunol; 1990; 2(1):51-6. PubMed ID: 2150920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic rearranged T cell receptor gene inhibits lymphadenopathy and accumulation of CD4-CD8-B220+ T cells in lpr/lpr mice.
    Mountz JD; Zhou T; Eldridge J; Berry K; Blüthmann H
    J Exp Med; 1990 Dec; 172(6):1805-17. PubMed ID: 1701823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
    Eshima K; Suzuki H; Shinohara N
    J Immunol; 2006 Feb; 176(3):1628-36. PubMed ID: 16424192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct differentiative stages of CD4+CD8+ thymocyte development defined by the lack of coreceptor binding in positive selection.
    Dutz JP; Ong CJ; Marth J; Teh HS
    J Immunol; 1995 Mar; 154(6):2588-99. PubMed ID: 7533178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
    Yasutomo K; Lucas B; Germain RN
    J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.